{"id":"W1986396848","doi":"10.1016/j.drup.2008.04.001","title":"Progress and challenges in the identification of biomarkers for EGFR and VEGFR targeting anticancer agents","year":2008,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Fondation de France; American Association for Cancer Research","keywords":"Medicine; Biomarker; Biomarker discovery; Trastuzumab; Imatinib; Drug; Clinical trial; Breast cancer; Druggability; Personalized medicine; Sunitinib; Oncology; Cancer; Pharmacology; Bioinformatics; Cancer research; Internal medicine; Biology; Proteomics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003677162,0.0009995464,0.003107333,0.00224134,0.0003081579,0.002197026,0.001473483,0.002154917,0.002660464],"category_scores_gemma":[0.002981515,0.0004550517,0.00075468,0.002217637,0.0009402516,0.003743763,0.0009906122,0.003409727,0.002186169],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001040179,"about_ca_system_score_gemma":0.001676799,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001271373,"about_ca_topic_score_gemma":0.002756026,"domain_scores_codex":[0.9992949,0.0001566828,0.0001080347,0.0001069582,0.0002826329,0.00005071443],"domain_scores_gemma":[0.997606,0.001450413,0.0001872551,0.00005305212,0.0006085731,0.00009462001],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001128313,0.0000857054,0.0002934376,0.006619154,0.00006901239,0.0002585523,0.00006676871,0.0004099519,0.001999021,0.005090586,0.02879531,0.9561997],"study_design_scores_gemma":[0.00004993793,0.0001891244,0.0009052514,0.002486888,0.0001480479,0.001879301,0.0001179815,0.0004180997,0.00122071,0.003689669,0.9888647,0.00003029195],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001372098,0.9974167,0.0004568161,0.001145093,0.0002474338,0.000004415627,0.00001099825,0.00001033076,0.0005708976],"genre_scores_gemma":[0.0009124487,0.9961607,0.0009761177,0.0007520724,0.0004816737,0.000009258033,0.00002989856,0.000003191516,0.0006745807],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003677162,"threshold_uncertainty_score":0.01944691,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1392766723441191,"score_gpt":0.4201719401740726,"score_spread":0.2808952678299535,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}